Letrozole in the Treatment of Severe and Recurrent Endometriosis
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Endometriosis is a condition in which abnormal growth of tissue histologically resembling the
lining of the uterus (endometrium) is present outside of the uterus. This study will
investigate the effect of a daily dose of letrozole compared to GnRH is safe and in addition
effective in reducing measurable endometriosis lesions and in reducing pain in patients with
active endometriosis which were pretreated with GnRH analogs for 2 months.